Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK3-IN-3 is a mitochondrial autophagy (mitophagy) inducer and GSK-3 inhibitor (IC50: 3.01 μM) that induces parkin-dependent mitochondrial autophagy. GSK3-IN-3 is non-ATP and non-substrate competitive and neuroprotective against 6-OHDA.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 79.00 | |
10 mg | In stock | $ 139.00 | |
25 mg | In stock | $ 289.00 | |
50 mg | In stock | $ 455.00 | |
100 mg | In stock | $ 669.00 |
Description | GSK3-IN-3 is a mitochondrial autophagy (mitophagy) inducer and GSK-3 inhibitor (IC50: 3.01 μM) that induces parkin-dependent mitochondrial autophagy. GSK3-IN-3 is non-ATP and non-substrate competitive and neuroprotective against 6-OHDA. |
Targets&IC50 | GSK-3:3.01 μM |
In vitro |
GSK3-IN-3 (VP07) (25 μM; 24 h) induces mitophagy in Parkin-expressing U2OS-iMLS cells, but with limited potency.[1] GSK3-IN-3 (1.56-25 μM; 24 h) causes mitochondrial fission and mitochondrial morphological changes in U2OS-iMLS-Parkin cells.[1] GSK3-IN-3 (VP0.7) (5 μM, 10 μM) showed neuroprotective effects against 6-OHDA in an in vitro cellular model of Parkinson's disease in SH-SY5Y cells.[2] |
Molecular Weight | 429.55 |
Formula | C24H35N3O4 |
CAS No. | 331963-27-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3.8 mg/mL (8.7 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK3-IN-3 331963-27-0 Autophagy PI3K/Akt/mTOR signaling Stem Cells GSK-3 Mitophagy inhibitor inhibit